Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Fortress Biotech Inc (FBIO)

Fortress Biotech Inc (FBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 39,434
  • Shares Outstanding, K 19,916
  • Annual Sales, $ 84,510 K
  • Annual Income, $ -60,640 K
  • 60-Month Beta 1.56
  • Price/Sales 0.46
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade FBIO with:

Options Overview Details

View History
  • Implied Volatility 35.57% ( -121.06%)
  • Historical Volatility 48.72%
  • IV Percentile 3%
  • IV Rank 0.45%
  • IV High 1,346.66% on 08/17/23
  • IV Low 29.60% on 10/11/23
  • Put/Call Vol Ratio 0.00
  • Today's Volume 52
  • Volume Avg (30-Day) 51
  • Put/Call OI Ratio 0.49
  • Today's Open Interest 1,540
  • Open Int (30-Day) 1,428

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -1.83
  • Number of Estimates 2
  • High Estimate -1.42
  • Low Estimate -2.24
  • Prior Year -3.60
  • Growth Rate Est. (year over year) +49.17%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.6500 +13.33%
on 05/10/24
2.0697 -9.65%
on 05/21/24
+0.1200 (+6.86%)
since 04/22/24
3-Month
1.6300 +14.72%
on 03/14/24
2.6150 -28.49%
on 03/04/24
+0.1200 (+6.86%)
since 02/22/24
52-Week
1.2400 +50.81%
on 11/10/23
10.6500 -82.44%
on 06/20/23
-6.0785 (-76.47%)
since 05/22/23

Most Recent Stories

More News
Fortress Biotech: Q1 Earnings Snapshot

Fortress Biotech: Q1 Earnings Snapshot

FBIO : 1.8700 (-5.56%)
Fortress Biotech: Q3 Earnings Snapshot

Fortress Biotech: Q3 Earnings Snapshot

FBIO : 1.8700 (-5.56%)
Fortress Biotech: Q2 Earnings Snapshot

Fortress Biotech: Q2 Earnings Snapshot

FBIO : 1.8700 (-5.56%)
Fortress Biotech: Q1 Earnings Snapshot

Fortress Biotech: Q1 Earnings Snapshot

FBIO : 1.8700 (-5.56%)
Earnings Preview: Fortress Biotech (FBIO) Q1 Earnings Expected to Decline

Fortress Biotech (FBIO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

FBIO : 1.8700 (-5.56%)
XENE : 38.80 (-0.46%)
Fulcrum Therapeutics, Inc. (FULC) Reports Q4 Loss, Misses Revenue Estimates

Fulcrum Therapeutics, Inc. (FULC) delivered earnings and revenue surprises of -2.04% and 64.29%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the...

FULC : 7.71 (+0.92%)
FBIO : 1.8700 (-5.56%)
Fortress Biotech (FBIO) Reports Q3 Loss, Misses Revenue Estimates

Fortress Biotech (FBIO) delivered earnings and revenue surprises of 7.41% and 13.09%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

FBIO : 1.8700 (-5.56%)
VERU : 1.3700 (-1.44%)
Bellus Health (BLU) Reports Q3 Loss, Misses Revenue Estimates

Bellus (BLU) delivered earnings and revenue surprises of -11.11% and 60%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

BLU : 14.74 (unch)
FBIO : 1.8700 (-5.56%)
Fortress Biotech: Q3 Earnings Snapshot

Fortress Biotech: Q3 Earnings Snapshot

FBIO : 1.8700 (-5.56%)
Twist Bioscience (TWST) Surges 16.1%: Is This an Indication of Further Gains?

Twist Bioscience (TWST) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down...

TWST : 43.09 (-2.16%)
FBIO : 1.8700 (-5.56%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Fortress Biotech, Inc. is a biopharmaceutical company. The company is engaged in acquiring, developing and commercializing novel pharmaceutical and biotechnology products. Fortress Biotech, Inc., formerly known as Coronado Biosciences, Inc., is based in NEW YORK, United States.

See More

Key Turning Points

3rd Resistance Point 2.1452
2nd Resistance Point 2.0821
1st Resistance Point 1.9761
Last Price 1.8700
1st Support Level 1.8070
2nd Support Level 1.7439
3rd Support Level 1.6379

See More

52-Week High 10.6500
Fibonacci 61.8% 7.0554
Fibonacci 50% 5.9450
Fibonacci 38.2% 4.8346
Last Price 1.8700
52-Week Low 1.2400

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar